Small Trial Suggests DMT Can Improve Symptoms of Depression

April 7, 2023 · Ganjapreneur

Woman patient having consultation with doctor (gynecologist or psychiatrist) and examining health in medical gynecological clinic or hospital mental health service center

A trial conducted by biotechnology company Small Pharma found that the psychedelic DMT could improve symptoms of depression when used in conjunction with therapy. In the study, which used intravenous DMT dosing, 14 participants out of 34 were in remission from depression within three months and nine remained in remission up to six months. 

The study, which utilized a proprietary synthetic formulation of DMT known as SPL026, has not been peer-reviewed. 

In a press release, Dr. Carol Routledge, chief medical and scientific officer at Small Pharma, said the team is “increasingly encouraged by the treatment potential” of the drug. 

The first part of the study involved 34 patients being given the treatment during a two-and-a-half-hour clinical session with a therapist and a therapy session followed which helped participants process their experience. The second part of the study followed participants for another three months after being administered the drug, and then six more months after the study had come to an end in an assessment of its durability. 

In a joint statement, Robin Carhart-Harris PhD, director of the psychedelics division at the Weill Institute for Neurosciences at the University of California San Francisco, and Ralph Metzner distinguished professor of Neurology, Psychiatry and Behavioral Sciences, said the study’s results suggest that the drug “can elicit a fast-acting antidepressant response that appears to be enduring in several cases.”

“Recent neuroimaging and preclinical findings imply a regenerative action with DMT and other related serotonergic agonists,” Carhart-Harris and Metzner said in the statement. (Full Story)

In categories:Psychedelics Research
Tags:
Next Post

Study: 1 in 10 Military Veterans Have Used Cannabis Over Past Year

A study published last month by researchers at the University of North Texas Health Science Center and College of Applied Health Sciences, University of Illinois at Urbana-Champaign found one in 10 military veterans reported using cannabis over the past year.   The study was published…
Read
Previous Post

My Dad Was Timothy Leary, 60s Drug Icon

What would you do if Nixon called your father the “the most dangerous man in America”? Tough question – but it’s one of many that stalked Zach Leary, now 49, as he grew up in the shadow of his dad,…
Read
Random Post

Drug that could nip America's fentanyl crisis in the bud: Cannabis compound can help reverse overdoses from the synthetic opioid, study shows

A chemical found in cannabis could be the most effective way to prevent an opioid overdose, scientists believe. Scientists at Indiana University have identified 15 chemicals derived from cannabidiol (CBD) — one of the primary compounds in cannabis — that can reverse…
Read
Random Post

GOP Congressman And AOC Refile Bill To Incentivize State-Level Marijuana Expungements

Reps. Dave Joyce (R-OH) and Alexandria Ocasio-Cortez (D-NY) have reintroduced a bipartisan bill to encourage state and local governments to expunge marijuana records in their jurisdictions. The lawmakers filed the Harnessing Opportunities by Pursuing Expungement (HOPE) Act on Tuesday, describing…
Read
Random Post

Mind Cure Limps To The Finished Line

After the market closed on Thursday, Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF)  announced its financial results for the quarter ending February 28, 2023.  All amounts are stated in Canadian dollars unless otherwise indicated. The company had no revenue to report and…
Read
Random Post

California Funds Research On Blocking Marijuana Monopolies And Protecting ‘Legacy’ Cannabis Strains

California officials announced on Wednesday that the state will be awarding up to $20 million in marijuana tax-funded grants to universities that carry out research into cannabis science and policy—including studies on preventing monopolies in the legal industry and securing…
Read